期刊文献+

奥美拉唑治疗消化性溃疡临床效果观察 被引量:7

下载PDF
导出
摘要 目的:探讨奥美拉唑治疗消化性溃疡的临床疗效。方法:选择2008年5月至2009年5月在我院治疗的60例消化性溃疡患者,随机分为治疗组和对照组,每组30例患者,治疗组用奥美拉唑治疗,对照组用泰胃美治疗,比较两组疗效和不良反应。结果:治疗组总有效率为93.3%,对照组治疗总有效率为66.7%,治疗组明显高于对照组,两组差异显著(P<0.05);治疗组不良反应发生率为6.7%,对照组不良反应发生率为10%,两组比较差异无统计学意义(P>0.05)。结论:奥美拉唑治疗消化性溃疡效果显著,不良反应少,是一种理想药物。
作者 秦建康
出处 《中国民族民间医药》 2010年第12期118-118,共1页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献2

二级参考文献16

  • 1Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus on the management of Helicobacterpylori infection. J Gastroenterol Hepatol, 1998,13: 1~12.
  • 2European Helicobacter pylori Study Group. Current European concepts in the management ofHelicobacter pylori infection. The Maastricht Consensus Report. Gut, 1997, 41: 8~13.
  • 3Miwa H, Ohkura R, Murai T, Sato K, NagaharaA, Hirai S, Watanabe S, Sato N. Impact of Rabeprazole, a new proton pump inhibitor, in tripletherapy of Helicobacter pylori infection-comparison with omeprazole and lansoprazole. AlimentPharmacol Ther, 1999, 13: 741~746.
  • 4Lind T, Veldhuyzen van Zanten S, Unge P, SpillerR, Bayerdorffer E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C,Idstrom JP. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.Helicobacter, 1996, 1: 138~144.
  • 5Besancon M, Simon A, Sachs G, Shin JM. Sites ofreaction of the gastric H, K-ATPase with extracytoplasmic thiol reagents. J Biol Chem, 1997,272: 22438~22446.
  • 6Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ. Comparison[correction of Double-blind, Placebo-Controlledcomparison] of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active gastric ulcer- a European multicentre study. The European Rabeprazole Study Group. Aliment Pharmacol Ther,1998, 12: 789~795.
  • 7Hongo M, Kimpara T, Moriyama S, Ohara S, SoneS, Tamura T, Asaki S, Toyota T. Effect of rabeprazole (E3810), a novel proton pump inhib- itor, oningastric pH in healthy volunteers. Tohodu J ExpMed, 1998, 186: 43~50.
  • 8Williams MP, Pounder RE. Review article: thepharmacology of rabeprazole. Aliment PharmacolTher, 1999, 13 (Suppl 3): S3~S10.
  • 9Thjodleifsson B, Beker JA, Dekkers C, Bjaaland T,Finnegan V, Humphries TJ. Rabeprazole versusomeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a doubleblind, multicenter, European trial. The EuropeanRabeprazole Study Group. Dig Dis Sci, 2000, 45:845 ~853.
  • 10Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in thetreatment of active duodenal ulcer: a Europeanmulticentre study. Aliment Pharmacol Ther, 1999,13: 179~186.

共引文献61

同被引文献22

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部